Federal Register / Vol. 89, No. 201 / Thursday, October 17, 2024 / Notices 83689 

Shortage Workgroup Update. Agenda 

items are subject to change as priorities 

dictate. 

Public Participation 

Written Public Comment: Members of 

the public are welcome to submit 

written comments in advance of the 

meeting. Written comments must be 

submitted by emailing nchhstppolicy@

cdc.gov with subject line ‘‘ACET 

December 2024 Public Comment 

Registration’’ by November 26, 2024. 

Oral Public Comment: Individuals 

who would like to make an oral 

comment during the public comment 

period must register by emailing 

nchhstppolicy@cdc.gov with subject 

line ‘‘ACET December 2024 Public 

Comment Registration’’ by November 

26, 2024. The public comment period is 

on December 4, 2024, at 10:15 a.m., 

EST. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2024–23885 Filed 10–16–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Meeting of the Board of Scientific 

Counselors, Office of Readiness and 

Response 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

Centers for Disease Control and 

Prevention (CDC) announces the 

following meeting for the Board of 

Scientific Counselors, Office of 

Readiness and Response (BSC, ORR). 

This is a virtual meeting and is open to 

the public, limited only by the number 

of web conference lines available (500 

lines). Time will be available for public 

comment. 

DATES: The meeting will be held on 

November 20, 2024, from 9:30 a.m. to 

4:30 p.m., EST, and November 21, 2024, 

from 9 a.m. to 3 p.m., EST. 

ADDRESSES: Zoom virtual meeting. If 

you wish to attend the meeting, please 

register in advance by accessing the link 

at https://cdc.zoomgov.com/webinar/ 

register/WN_

sIWaL9XVRqWnBKMB2OO2wQ#/ 

registration. Instructions on accessing 

the meeting will be provided following 

registration. 

FOR FURTHER INFORMATION CONTACT: 

Dometa Ouisley, Public Health Analyst, 

Office of Science and Laboratory 

Readiness, Office of Readiness and 

Response, Centers for Disease Control 

and Prevention, 1600 Clifton Road NE, 

Mailstop H21–6, Atlanta, Georgia 

30329–4027. Telephone: (404) 639– 

7450; Email: DOuisley@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: The Board of Scientific 

Counselors, Office of Readiness and 

Response provides advice and guidance 

to the Secretary, Department of Health 

and Human Services (HHS); the 

Assistant Secretary for Health, HHS; the 

Director, Centers for Disease Control 

and Prevention (CDC); and the Director, 

Office of Readiness and Response 

(ORR), CDC. The Board recommends 

strategies and goals for readiness and 

response activities pertaining to 

programs and research within the 

agency and the ORR divisions and 

monitors the overall strategic direction 

and focus of the ORR divisions and 

offices. The Board may also perform 

second-level peer review of applications 

for grants-in-aid for research and 

research training activities, cooperative 

agreements, and research contract 

proposals relating to the broad areas 

within the center. For additional 

information about the Board, please 

visit https://www.cdc.gov/orr/scientificcounselors/index.html. 

Matters to be Considered: Agenda 

topics for Day 1 of the meeting include 

ORR Updates, ORR Division Director 

Updates, CDC’s Response Readiness 

Framework, and a CDCReady 

Demonstration. Agenda topics for Day 2 

include Poliovirus Containment 

Working Group Updates, ORR Science 

Agenda Working Group Updates, and 

Health Equity Working Group Updates. 

Agenda items are subject to change as 

priorities dictate. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2024–23926 Filed 10–16–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–3466–PN] 

Medicare and Medicaid Programs: 

Application From the American 

Association for Accreditation of 

Ambulatory Surgery Facilities dba 

QUAD A for Continued CMS-Approval 

of Its Outpatient Physical Therapy 

(OPT) Accreditation Program 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), HHS. 

ACTION: Notice with request for 

comment. 

SUMMARY: This notice acknowledges the 

receipt of an application from the 

American Association for Accreditation 

of Ambulatory Surgery Facilities, dba 

QUAD A, for continued recognition as 

a national accrediting organization for 

outpatient physical therapy providers 

that wish to participate in the Medicare 

or Medicaid programs. 

DATES: To be assured consideration, 

comments must be received at one of 

the addresses provided below, no later 

than 5 p.m. on November 18, 2024. 

ADDRESSES: In commenting, refer to file 

code CMS–3466–PN. Because of staff 

and resource limitations, we cannot 

accept comments by facsimile (FAX) 

transmission. 

Comments, including mass comment 

submissions, must be submitted in one 

of the following three ways (please 

choose only one of the ways listed): 

1. Electronically. You may submit 

electronic comments on this regulation 

to https://www.regulations.gov. Follow 

the ‘‘Submit a comment’’ instructions. 

2. By regular mail. You may mail 

written comments to the following 

address ONLY: Centers for Medicare & 

Medicaid Services, Department of 

Health and Human Services, Attention: 

CMS–3466–PN, P.O. Box 8010, 

Baltimore, MD 21244–8010. 


ddrumheller on DSK120RN23PROD with NOTICES1